UCL spin-out partners with gene therapy firm on eye drug pipeline
University College London is forming a spin-out gene therapy company to develop large molecule treatments for eye disease.
Archives for November 27, 2015
AbbVie ready to defend Humira's IP after Amgen files biosimilar
Amgen has submiited its Humira biosimilar for regulatory review in what it believes is the first challenge to AbbVie's blockbuster biologic in the US.
UK-Japan pact to speed regenerative meds to market
The UK and Japan plan to work together on breaking into each other’s markets with regenerative medicines.